We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Proposes Tougher Guidelines For Advisers

Law360 (March 21, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration released draft guidelines Wednesday that would keep individuals with interests of over $50,000 in drug and medical device companies from participating in the agency’s advisory committees.

The FDA said the guidelines, which are subject to public comment for 60 days before they are finalized, are part of its new stricter line against potential conflicts of interest for its advisory committee members.

“FDA is committed to making the advisory committee process more rigorous and transparent so that the public has confidence...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.